The Innovation Observatory performed a scan of radioligand technologies (imaging and therapeutic) in May 2021, using robust horizon scanning methods to identify promising innovations and to anticipate technological trends.
We developed a detailed dataset of technologies by formulating search strategies for radioligand, based on a comprehensive list of terms and input from expert panels. Primary and secondary sources were systematically scanned using a combination of traditional scanning methods, automated and novel AI/machine learning techniques.
Sources included clinical trial registries, MedTech news, academic sources, funding agencies, commercial sites and regulatory authorities. Together the insights provide a comprehensive landscape to allow decision-makers and HTAs to consider the clinical, financial, infrastructural and logistical provisions to improve preparedness for the potential adoption of these future innovations.